Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health problems news

Show

From To
Pretreatment HIV, immune activation levels determine their persistence during treatment

A study led by a Massachusetts General Hospital investigator finds that pretreatment levels of HIV and immune activation appear to determine the extent to which viral levels and inflammation persist during antiretroviral treatment.

Published
25 April 2017
From
Eurekalert Inf Dis
Direct-acting antivirals for hepatitis C not linked to higher liver cancer risk in most studies

People with hepatitis C who take treatment with direct-acting antivirals (DAAs) do not appear to have a higher risk of developing liver cancer compared to those treated with

Published
21 April 2017
By
Liz Highleyman
Curing hepatitis C reduces cardiovascular risk

Curing hepatitis C reduces the risk of cardiovascular events in people with compensated cirrhosis, a large French study presented this week at the International Liver Congress in

Published
20 April 2017
By
Keith Alcorn
HIV Infection, Heart Failure Go Together

HIV-positive individuals had an increased risk of several types of heart failure compared to individuals without the disease, a large epidemiologic study found.

Published
10 April 2017
From
MedPage Today HIV/AIDS
In 2030, the Top Cancer in HIV Patients May Be a Surprise

The burden of cancer among people living with HIV in the United States is undergoing notable change, according to new research presented here at the American Association for Cancer Research (AACR) 2017 Annual Meeting. In 2030, the most common cancers among people with HIV will be prostate, lung, and liver cancer, they report.

Published
05 April 2017
From
Medscape (requires registration)
Vaccine credited with HPV virus reduction in Scotland

Researchers find a 90% reduction in the number of women infected with human papilloma virus since 2008.

Published
05 April 2017
From
BBC Health
Poppers linked to increased risk of some cancers in older MSM without HIV

Daily or weekly use of poppers over a number of years is associated with a substantial increase in the risk of cancers caused by viruses

Published
04 April 2017
By
Keith Alcorn
Co-infection with HCV increases cancer risk for people with HIV

People with HIV and hepatitis C virus (HCV) co-infection have an increased risk of non-AIDS-defining cancers compared to people with HIV mono-infection, investigators from Spain report in the

Published
31 March 2017
By
Michael Carter
Bone density improves in people who switch from tenofovir DF to tenofovir alafenamide

After three years, tenofovir alafenamide (TAF) for first-line HIV treatment was better at suppressing viral load and safer for the bones and kidneys than the older tenofovir

Published
27 March 2017
By
Liz Highleyman
Are serious heart problems inevitable for people with HIV? A conversation with cardiologist Priscilla Hsue

Priscilla Hsue, MD, FACC, a cardiologist at Zuckerberg San Francisco General Hospital spoke about heart health and inflammation, and why cardiovascular conditions are becoming a growing concern for people growing older with HIV.

Published
16 March 2017
From
BETA blog

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.